BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern Time
-
Missed penalty spurred 'very angry' Messi to World Cup history
-
Shooting in Montreal, Canada leaves three dead including suspect
-
Oil falls as US waives Iranian sanctions and Nasdaq tumbles
-
Balogun chases 'inevitable' Messi in wild Golden Boot race
-
Defeated Colombian leftist calls for calm after post-vote violence
-
Belgium's Doku becomes father after World Cup controversy
-
Messi sets World Cup scoring record as Argentina down Austria
-
Magic Messi makes World Cup history to send Argentina into last 32
-
French TV presenter stood down over Doku World Cup comments
-
Ghana coach Queiroz says playing England 'easiest' World Cup game
-
Messi sets World Cup scoring record with 17th goal
-
Former Bayern stalwart Demichelis takes over at RB Leipzig
-
Colombian leftist candidate calls for calm after post-vote violence
-
Andy Burnham: 'King of the North' with Downing Street in his sights
-
Britons cautiously optimistic after PM's resignation
-
Latest developments in Europe's heatwave
-
Draper makes winning return at Eastbourne with Murray on his side
-
IMF director says Iran war fallout creating 'difficult moment' for Africa
-
Argentina fans defiant, 40 years on from Maradona's 'Hand of God'
-
Hormuz: Traffic flows despite Iran's closure announcement
-
Wikipedia won't let AI edit articles, cofounder says
-
Clive Davis: the starmaker who shaped modern music
-
Uncapped Coles named in England's T20 squad to face India
-
Qatar gas plant blast kills 13, injures dozens
-
Andy Burnham: 'King of the North' eyes Downing Street throne
-
Oil falls as US waives Iranian crude sanctions
-
Dangerous 'heat stress' has surged worldwide, study shows
-
England captain Itoje rested for Nations Championship
-
Interstellar comet likely far older than Solar System: astronomers
-
Antoine Semenyo, Ghana's man on the inside and England threat
-
Man Utd secure land for proposed new 100,000-capacity stadium
-
Two children found dead in car as France faces hottest day of heatwave
-
US suspends Iran oil sanctions, says nuclear inspectors to return
-
Two children die in France as heatwave blasts Europe
-
Stokes and Atkinson cleared by Cricket Regulator after nightclub incident
-
Ex-Wimbledon champion Vondrousova banned four years for refusing drugs test
-
Veteran Le Roy named new coach of Congo
-
Milan-Cortina chief Malago elected new head of Italian FA
-
Germany's Schlotterbeck out of World Cup with ankle injury
-
Any unfreezing of Iranian funds will not finance terrorism: Vance
-
Vance hails 'good foundation' for Iran deal after direct talks
-
Alan Greenspan: longtime Fed chief with a divided legacy
-
Leinster boss Cullen to step down at end of next season
-
'Has-been' Belgium stars scorched after Iran World Cup draw
-
Oil falls on US-Iran progress; pound holds up as Starmer resigns
-
Starmer resigns as UK PM, Burnham favourite to take over
-
France, Germany reach deal on arms maker KNDS, paving way for IPO
-
Latest developments on Europe's heatwave
-
France set for hottest day yet of heatwave
-
Keir Starmer: downfall of UK's unpopular PM
BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern Time
WESTMINSTER, CA / ACCESS Newswire / November 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Friday, November 14th, 2025, at 1:30 pm Pacific / 4:30 pm Eastern. The event, which will be open to the public, will be held to review the company's financial results for the three months ending September 30th, 2025, discuss recent milestones, and conduct a question-and-answer session.
To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.
To participate in the live webcast and teleconference:
Webcast Link: | |
Teleconference Domestic: | 877-545-0320 |
Teleconference International: Participant Access Code: | +1-973-528-0002 517720 |
To watch or listen to a replay of the webcast or teleconference:
Teleconference Replay Expiration: | Sunday, February 14th, 2027 |
Teleconference Replay Domestic: | 877-481-4010 |
Teleconference Replay International: | 919-882-2331 |
Replay Passcode: | 53245 |
The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.
About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
SOURCE: BioLargo, Inc
View the original press release on ACCESS Newswire
D.Lopez--AT
